On June 24, 2025, T-E Meds and Asymchem Laboratories successfully signed a strategic cooperation agreement. This partnership marks the beginning of a deep strategic collaboration in the field of innovative drug development, with the goal of jointly advancing the global pharmaceutical industry. Ms. Yang Rui, Co-CEO of Asymchem, and Dr. Hsin-Mao Chu, CEO of T-E … Continue reading T-E Meds and Asymchem Join Forces to Drive Innovation in Drug Conjugates and Explore the Future of Targeted Therapeutics